GB-103

N/A

Report date: 2022/09/07 15:51:41
NME

Base Information

Drug NameGB-103
Drug Alias NameGB-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cells modulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companies1globe Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active Companies1globe Biomedical Llc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A